CRVO
NASDAQ
$2.79
CervoMed Inc (CRVO)
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. The company is headquartered in Boston, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $19.50 (+598.92%)
Market Cap
$28M
Free Cash Flow Yield
-97.01%
Beta (5Y)
1.36
Price Chart
Valuation
Market Cap$28M
P/S13.61
P/B2.69
Profitability
Total Revenue (TTM)$2.09M
Gross Profit (TTM)-$20M
EBITDA-$30M
Operating Margin-1489%
EPS-$3.25
Financial Health
Free Cash Flow Yield-97.01%
Growth & Risk
EPS 5Y CAGR-27.64%
FCF 5Y CAGR+15.26%
Beta (5Y)1.36
Sharpe Ratio-0.42